Generic Market in Mexico up to 84%

Posted on

Regulatory Affairs in Latin America

The volume of generic drug products consumed by the Mexican population grew from 54% to 84% in the last three years, was announced by Mikel Arriola, Commissioner for the COFEPRIS, the Mexican regulatory agency. The announcement was made at the opening of a training session on marketing authorization of allopathic medicines of the Interchangeable Generic Drug Product Manufacturers Mexican Association (Asociación Mexicana de Fabricantes de Medicamentos Genéricos Intercambiables – AMEGI).

Dr. Arriola highlighted that Mexico is a the world leader in generic drug consumption, and that the Mexican people has overcome the myth that generic products are of poorer quality, safety and efficacy profile than those offered by innovative brands. He also mentioned that, thanks to expedite approval of these products, considerable savings are possible, both of out-of-pocket medicines expenditure, and public healthcare costs. Generic products now represent 52% of market share, the remaining 48% corresponding to innovatives.

View original post 163 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s